Dr. Peter Breggin (MD) – Psychiatry, neurosurgery, psychopharmacology and mind control politics


Further References

Breggin, P. R.. (1998). Analysis of Adverse Behavioral Effects of Benzodiazepines With a Discussion on Drawing Scientific Conclusions from the FDA’s Spontaneous Reporting System. The Institute of Mind and Behavior, Inc.
Breggin, P. R.. (2000). The NIMH multimodal study of treatment for attention-deficit/hyperactivity disorder: A critical analysis. [References]. International Journal of Risk & Safety in Medicine
Breggin, P. R.. (1998). Electroshock: scientific, ethical, and political issues *. International Journal of Risk & Safety in Medicine
Breggin, P. R.. (2014). The rights of children and parents in regard to children receiving psychiatric diagnoses and drugs. Children and Society

Plain numerical DOI: 10.1111/chso.12049
DOI URL
directSciHub download

Breggin, P. R.. (2004). Recent U.S., Canadian and British regulatory agency actions concerning antidepressant-induced harm to self and others: A review and analysis. International Journal of Risk & Safety in Medicine
Breggin, P. R.. (2006). Intoxication Anosognosia: The Spellbinding Effect of Psychiatric Drugs. Ethical Human Psychology and Psychiatry, 8(3), 201–216.

Plain numerical DOI: 10.1891/ehppij-v8i3a003
DOI URL
directSciHub download

Breggin, P. R.. (2003). Psychopharmacology And Human Values. Journal of Humanistic Psychology, 43(2), 34–49.

Plain numerical DOI: 10.1177/0022167802250729
DOI URL
directSciHub download

Karon, P., & Breggin, R.. (2012). Review of Psychiatric drug withdrawal: A guide for prescribers, therapists, patients and their families.. Ethical Human Psychology and Psychiatry: An International Journal of Critical Inquiry
Breggin, P. R.. (2002). Fluvoxamine as a cause of stimulation, mania and aggression: A critical analysis of the FDA-approved label. Ethical Human Sciences & Services
Breggin, P. R.. (2010). Antidepressant-induced suicide, violence and mania: Risks for military personnel. International Journal of Risk and Safety in Medicine

Plain numerical DOI: 10.3233/JRS-2010-0502
DOI URL
directSciHub download

Breggin, P. R.. (2011). Psychiatric drug-induced Chronic Brain Impairment (CBI): Implications for long-term treatment with psychiatric medication. International Journal of Risk and Safety in Medicine

Plain numerical DOI: 10.3233/JRS-2011-0542
DOI URL
directSciHub download

Breggin, P. R., & Breggin, G.. (2008). Exposure to SSRI Antidepressants In Utero Causes Birth Defects, Neonatal Withdrawal Symptoms, and Brain Damage. Ethical Human Psychology and Psychiatry, 10(1), 5–9.

Plain numerical DOI: 10.1891/1559-4343.10.1.5
DOI URL
directSciHub download

Breggin, P. R.. (2016). Rational Principles of Psychopharmacology for Therapists, Healthcare Providers and Clients. Journal of Contemporary Psychotherapy, 46(1), 1–13.

Plain numerical DOI: 10.1007/s10879-015-9307-2
DOI URL
directSciHub download

Breggin, P. R.. (2015). The biological evolution of guilt, shame and anxiety: A new theory of negative legacy emotions. Medical Hypotheses

Plain numerical DOI: 10.1016/j.mehy.2015.03.015
DOI URL
directSciHub download

Leave a Reply

Your email address will not be published. Required fields are marked *

+ 6 = 16